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Previously, we identified five genes (Cj1321 to Cj1326, of which Cj1325 and Cj1326 are a single gene) in the
O-linked flagellin glycosylation island that are highly prevalent in Campylobacter jejuni isolates from chickens.
We report mutagenesis, functional, and structural data to confirm that this locus, and Cj1324 in particular, has
a significant contributory role in the colonization of chickens by C. jejuni. A motile Cj1324 mutant with intact
flagella was considerably less hydrophobic and less able to autoagglutinate and form biofilms than the parent
strain, 11168H, suggesting that the surface charge of flagella of Cj1324-deficient strains was altered. The
physical and functional attributes of the parent were restored upon complementation. Structural analysis of
flagellin protein purified from the Cj1324 mutant revealed the absence of two legionaminic acid glycan
modifications that were present in the parent strain, 11168H. These glycoform modifications were shown to be
prevalent in chicken isolates and confirm that differences in the highly variable flagellin glycosylation locus can
relate to the strain source. The discovery of molecular mechanisms influencing the persistence of C. jejuni in
poultry aids the rational design of approaches to control this problematic pathogen in the food chain.
Campylobacter jejuni is the leading bacterial cause of human
gastroenteritis worldwide (7). Infection can cause symptoms
including abdominal pain and fever with watery to bloody
diarrhea (54). Occasionally, postinfectious sequelae follow C.
jejuni infection and include reactive arthritis and Guillain-
Barre´ syndrome (8). Recently, C. jejuni has been associated
with immunoproliferative small intestine disease, which is a
rare type of mucosa-associated lymphoid tissue lymphoma
(31). The main source of transmission through the food chain
is the consumption and handling of contaminated poultry, but
the underlying reasons why chickens are particularly suscepti-
ble to colonization by C. jejuni are unknown (15). C. jejuni has
also been recovered from nonavian livestock, unpasteurized
milk, and contaminated water (7). The socioeconomic burden
of this pathogen means that it is imperative that ways of re-
ducing the levels of C. jejuni in the food chain, particularly
poultry, are investigated.
The glycosylation of flagellin in a number of gram-negative
pathogenic bacteria, including Pseudomonas aeruginosa, Heli-
cobacter pylori, and Aeromonas spp., is increasingly recognized
as playing significant roles (2, 24, 32, 43, 49). Glycosylation
modifications have been shown to influence the cell’s immu-
nogenicity, interaction with eukaryotic cells, and host cell spec-
ificity. Aeromonads are waterborne bacteria that can cause
disease in fish, reptiles, and amphibians. Mesophilic aero-
monads are important human pathogens causing gastrointes-
tinal infections and, in severe cases, wound disease and septi-
cemia in healthy and immunocompromised patients (63).
Flagella of the mesophilic aeromonad Aeromonas caviae have
been shown to be glycosylated (43) with a derivative of
pseudaminic acid (50). In the plant pathogen Pseudomonas
syringae pv. glycinea, the mutation of three genes located in a
flagellin glycosylation island results in alterations to host spec-
ificity (61). Mutants of P. syringae pv. glycinea fail to cause
symptoms in the normal host, soybean plants, but can grow on
nonhost tobacco leaves, causing symptom-like changes on
leaves. Takeuchi et al. proposed that the posttranslational
modification of flagellin may be an adaptation of the bacterium
to avoid recognition by host defenses (61). In P. aeruginosa
strain PAK, a flagellin glycosylation island comprising 14 genes
was discovered and shown to cause glycosylation exclusively for
P. aeruginosa isolates expressing a-type flagellin (2). Further
studies have shown that there appears to be variation in the
glycosylation islands of strains containing the a-type flagellin
(4). A glycosylation island comprising four genes in the type b
flagellin strain P. aeruginosa PAO has been found. When a
mutant unable to glycosylate flagellin was tested in a murine
model of burn wound infection, it exhibited a reduction in
virulence compared to that of the wild type (3). Thus, it ap-
pears that in P. aeruginosa different glycoforms on the flagellin
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are required for the colonization of different hosts or environ-
ments and that these glycoforms may provide the bacterium
with a specific survival advantage.
We recently examined 111 strains of C. jejuni, including
human, chicken, bovine, ovine, and environmental isolates,
using comparative phylogenomics (whole-genome compari-
sons of microbes using DNA microarrays combined with
Bayesian-based phylogenies) (10). Isolates fell into two distinct
clades, which based on the origins of the isolates were defined
as livestock-associated and non-livestock-associated clades.
Over 40 genes were identified as being significantly prevalent
in either of the clades. Among these was a set of six genes,
Cj1321, Cj1322, Cj1323, Cj1324, Cj1325, and Cj1326 (as iden-
tified in the initial annotation by Parkhill et al. for the original
sequenced C. jejuni strain, NCTC11168 [42]), that lie within a
region of the genome encoding the flagellin O-linked glycosyl-
ation system. Thus, although genes Cj1321 to Cj1326 are lo-
cated within a region of the genome which has variability, they
are conserved among some C. jejuni strains that are often
associated with livestock. Microarray data have shown that the
six genes are all transcribed in the same orientation, but it is
unknown if they are an operon (N. Dorrell and B. W. Wren,
unpublished data). NCTC11168 has since been reannotated,
and as a result, Cj1325 and Cj1326 are now considered to be
one gene, hereinafter referred to as Cj1325/6 (22). Previous
BLAST analyses have shown that the Cj1321 protein has
amino acid similarity to many bacterial acetyl transferases,
both Cj1322 and Cj1323 proteins are similar to hydroxyacyl
dehydrogenases, and the product of Cj1324 is similar to
WbpG, a protein involved in lipopolysaccharide synthesis in
many bacteria.
In C. jejuni NCTC11168 (the original sequenced strain,
found in the livestock clade), the O-linked flagellar glycosyla-
tion system is thought to consist of a cluster of approximately
50 genes (Cj1293 to Cj1342) adjacent to flaA and flaB which
encode the structural flagellin proteins (42). The full glycan
structure(s) in NCTC11168 (and most other strains associated
with livestock) is unknown, but given the considerably larger
size of the O-linked glycosylation loci in the livestock-associ-
ated strains than in the non-livestock-associated strains, it is
likely that the livestock-associated strains may have additional
modifications to the pseudaminic acid basic structure, as well
as other unique glycan moieties, compared to those of the
non-livestock-associated strains. The flagellin O-linked glyco-
sylation locus in C. jejuni 81-176 (a frequently studied human
strain found in the non-livestock-associated clade) is far sim-
pler than that in C. jejuni NCTC11168, comprising just 26
genes (21). Two modifications predominantly decorate FlaA
and FlaB of strain 81-176, the nine-carbon sugar pseudaminic
acid (5,7-diacetamido-3,5,7,9-tetradeoxy-L-glycero--L-manno-
nonulosonic acid [Pse5Ac7Ac]) and an acetamidino form
of pseudaminic acid, 5-acetamido-7-acetamidino-3,5,7,9-tetra-
deoxy-L-glycero--L-manno-nonulosonic acid (Pse5Ac7Am).
Derivatives of Pse5Ac7Am also decorate the flagellin of 81-176
in minor quantities (34, 37, 62). Genetic analysis of 81-176
showed that pse genes are involved in the biosynthesis of
pseudaminic acid and its derivatives (21, 37, 62). More re-
cently, the full biosynthetic pathway for pseudaminic acid was
determined; in a six-step reaction, UDP-N-acetylglucosamine
(UDP-GlcNAc) is converted to pseudaminic acid through the
actions of PseB/Cj1293, PseC/Cj1294, PseH/Cj1313, PseG/
Cj1312, PseI/Cj1317, and PseF/Cj1311 proteins (The Cj desig-
nations refer to predicted coding sequences in C. jejuni
NCTC11168) (11, 19, 21, 35, 52, 62).
The most detailed analysis of the flagellin O-linked glycosy-
lation locus has been undertaken with C. jejuni strain 81-176
and the related species Campylobacter coli (strain VC167) (34).
Structural studies of the flagellum modifications of C. coli
VC167 revealed that in addition to Pse5Ac7Ac, acetamidino
and N-methylacetimidoyl derivatives of legionaminic acid
[5-acetamidino-7-acetamido-3,5,7,9-tetradeoxy-D-glycero-D-
galacto-nonulosonic acid (Leg5Am7Ac) and 5-E/Z-N-(N-
methlyacetimidoyl)-7-acetamidino-3,5,7,9-tetradeoxy-D-
galacto-nonulosonic acid (Leg5AmNMe7Ac), respectively]
decorate the C. coli flagellin, the first demonstration of a le-
gionaminic acid derivative modification of bacterial flagellin
(36). Biosynthesis of these legionaminic acid derivatives in-
volves a distinct pathway encoded by the posttranslational
modification (ptm) genes (34, 36). Although the precise path-
way for the production of legionaminic acid has yet to be
determined, tentative functions have been assigned which have
identified PtmA to PtmH to be required for biosynthesis
(PtmA, PtmB, PtmC, PtmD, PtmE, PtmF, PtmG, and PtmH
are equivalent to the Cj1332, Cj1331, Cj1327, Cj1328, Cj1329,
Cj1330, Cj1324, and Cj1325/6 proteins, respectively) (36). This
ptm pathway is absent in C. jejuni strain 81-176. PtmG and
PtmH from C. coli VC167 show 86 and 76% amino acid se-
quence similarity, respectively, to two hypothetical proteins,
the Cj1324 and Cj1325/6 proteins of C. jejuni NCTC11168. The
enzyme(s) involved in the attachment of glycan(s) to the flagel-
lin protein of Campylobacter strains and the consensus se-
quence for the O-linked glycosylation process have yet to be
identified.
In C. jejuni strain 81-176, glycosylation of flagellin has been
shown to be necessary for the assembly of flagella and subse-
quent motility (19). There is extensive polymorphism in the C.
jejuni O-linked glycosylation cluster, suggesting that selective
pressure may cause the bacterium to alter surface antigens in
attempts to evade the host immune defenses (59). Evidence
supporting this possibility is demonstrated by comparing the
glycan moieties of the flagella of C. jejuni 81-176 and C. coli
VC167, as these strains produce unique modifications on their
flagella which affect serospecificity (34).
Given the diversity of the O-linked glycosylation system in C.
jejuni and the prevalence of the locus of Cj1321 to Cj1325/6 in
chicken isolates, we hypothesized that these genes may be
important for the abilities of some C. jejuni strains to colonize
poultry and that colonization may be mediated through struc-
tural and surface charge changes in the glycan that modifies the
flagellin. In this study, we demonstrate that Cj1324 is involved
in the biosynthesis of two novel legionaminic acid modifica-
tions found on the flagellin of strain 11168H. The presence of
these modifications affects autoagglutination, cell charge, and
the efficiency with which C. jejuni 11168H colonizes chickens.
MATERIALS AND METHODS
Bacterial strains and growth media. All bacterial strains used in this study are
shown in Table 1. C. jejuni strain 11168H is a hypermotile variant of the se-
quenced strain NCTC11168 that readily colonizes chickens (29). C. jejuni strains
were cultured on Columbia blood agar (CBA) plates with Skirrow selective
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supplement (Oxoid, United Kingdom) and 7 to 9% horse blood in a variable-
atmosphere incubator (VAIN; Don Whitley Scientific, United Kingdom) under
microaerobic conditions (5% O2, 85% N2, and 10% CO2) at 37°C for 24 or 48 h.
Where necessary, CBA plates were supplemented with the antibiotics kanamycin
(50 g/ml) and chloramphenicol (30 g/ml). C. jejuni strains were stored at
80°C in a 12.5% solution of glycerol in Mueller-Hinton broth. Escherichia coli
strains XL-1 (Stratagene, La Jolla, CA) and Top10 (Invitrogen, Paisley, United
Kingdom) were used for cloning experiments and grown on Luria-Bertani agar
or in Luria-Bertani broth at 37°C.
Electroporation. The electroporation procedure for C. jejuni strains was sim-
ilar to the method described by Karlyshev and Wren (30). C. jejuni from glycerol
stock was grown on CBA with the supplements listed above at 37°C for 48 h
under microaerophilic conditions in a VAIN. Strains were restreaked and grown
under the same conditions for 24 h. Growth from half a plate was resuspended
in 1 ml of Mueller-Hinton broth, and the suspension was centrifuged at 13,000
rpm for 5 min. The supernatant was discarded, and the pellet was resuspended
and washed in 1 ml of ice-cold wash buffer (272 mM sucrose and 15% glycerol)
and centrifuged at 13,000 rpm for 5 min. Cells were washed three times, and then
100-l aliquots were used for each electroporation. After the addition of 1 to 5
g of DNA, the mixture was transferred into an ice-cold electroporation cuvette
and the cuvette was incubated on ice for 30 min. Electroporation was performed
at 2.5 kV, 200 , and 25 F using the GenePulser Xcell system (Bio-Rad, Hemel
Hempstead). The cuvette was flushed with 100 l of superoptimal broth with
catabolite repression (Sigma-Aldrich, United Kingdom), and cells were plated
onto a nonselective CBA plate and grown with the plate upright for 24 h at 37°C.
Bacteria were then plated onto selective plates and grown for a further 3 to 5
days.
Preparation of chromosomal DNA and general cloning techniques. Chromo-
somal DNA was extracted from C. jejuni by using a Puregene DNA purification
kit per the instructions of the manufacturer (Gentra Systems). Purified DNA was
stored at 20°C. Plasmid pRRC was used to complement all gene knockouts in
C. jejuni strains. A description of the construction of and further details for this
plasmid are given elsewhere (30).
Plasmids pUC18 and pUC19 (Fermentas, United Kingdom) were used for
cloning. Plasmid DNA purification was performed using a Qiaprep spin miniprep
kit (Qiagen, United Kingdom). Oligonucleotide primers were synthesized by
Sigma-Aldrich Genosys Ltd. (Haverhill, United Kingdom). Restriction endonu-
clease enzymes and T4 DNA ligase were purchased from Promega (Southamp-
ton, United Kingdom). Standard restriction digestion, DNA ligation, and cloning
procedures were as described elsewhere (48). Antarctic phosphatase was pur-
chased from New England Biolabs (Ipswich, United Kingdom) and was used to
dephosphorylate XbaI-treated pRRC according to the manufacturer’s instruc-
tions.
Construction of Cj1321, Cj1322, Cj1323, Cj1324, and Cj1325/6 mu-
tants. Site-specific mutations in C. jejuni Cj1322, Cj1324, and Cj1325/6 were
generated via the insertion of a kanamycin resistance cassette (Kanr) into unique
sites present within appropriate pUC18-based recombinant plasmids from a
random genomic library of C. jejuni (NCTC11168) that were constructed during
the course of the genome-sequencing project (42) (Table 2). The Kanr cassette
was inserted in a nonpolar orientation, and the derivatives were used for the
transformation of the C. jejuni 11168H strain via electroporation. Mutations
were verified by PCR using gene-specific and kanamycin cassette-specific prim-
ers. Cj1321 and Cj1323 mutants were constructed by inverse PCR (IPCR)
using plasmid cam169b1 from the NCTC11168 genome-sequencing library as a
template (primer details are given in Table 3). The 1.9-kb insert in this plasmid
contains full copies of Cj1321 and Cj1323. A BamHI fragment of plasmid
pJMK30 containing the Kanr cassette was blunt ended by T4 DNA polymerase.
To construct the Cj1321 mutant, the IPCR product generated using primers
ak338 and ak339 was blunt ended by T4 DNA polymerase and ligated to the Kanr
cassette. To construct the Cj1323 mutant, an IPCR product generated using
TABLE 1. Strains used in this study
Strain or mutationa Genotype or description Reference or source
C. jejuni strains and mutations
11168H Hypermotile derivative of sequenced strain
C. jejuni 11168
A. Karlyshev
Cj1321 Cj1321::Kanr This study
Cj1321 comp strain Cj1321::Kanr complement This study
Cj1322 Cj1322::Kanr This study
Cj1322 comp strain Cj1322::Kanr complement This study
Cj1323 Cj1323::Kanr This study
Cj1323 comp strain Cj1323::Kanr complement This study
Cj1324 Cj1324::Kanr This study
Cj1324 comp strain Cj1324::Kanr complement This study
Cj1325/6 Cj1325/6::Kanr This study
Cj1325/6 comp strain Cj1325/6::Kanr complement This study
(Cj1321-Cj1325/6) (Cj1321-Cj1325/6)::Kanr This study
(Cj1321-Cj1325/6) comp strain (Cj1321-Cj1325/6)::Kanr complement This study
flaA flaA::Kanr A. Karlyshev
11856 Livestock-associated clade strain Campylobacter Reference Lab, United Kingdom
12450 Livestock-associated clade strain Campylobacter Reference Lab, United Kingdom
12567 Livestock-associated clade strain Campylobacter Reference Lab, United Kingdom
12241 Non-livestock-associated clade strain Campylobacter Reference Lab, United Kingdom
15168 Non-livestock-associated clade strain Campylobacter Reference Lab, United Kingdom
31467 Non-livestock-associated clade strain Campylobacter Reference Lab, United Kingdom
43983 Non-livestock-associated clade strain Campylobacter Reference Lab, United Kingdom
80646 Non-livestock-associated clade strain Campylobacter Reference Lab, United Kingdom
E. coli strains
Top10F Invitrogen (Paisley, United Kingdom)
XL-1 Stratagene
XL2-Blue MRF Stratagene
a Comp, complemented.
TABLE 2. pUC18-based plasmids used for mutagenesis
Gene
mutated
Plasmid from
pUC18 library
Insert
size (kb) Insertion site
Distance from
gene start (%
of gene size)
Cj1322 cam136d10 1.3 SwaI 77
Cj1324 cam19f3 1.3 EcoRV 34
Cj1325/6 cam165f10 1.9 ClaI 80
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primers ak340 and ak341 was blunt-ended by T4 DNA polymerase and ligated to
a blunt-ended BamHI DNA fragment containing the Kanr cassette. Following
the transformation of E. coli XL2-Blue MRF cells, the recombinant plasmids
were verified by restriction analysis and sequencing, and C. jejuni strain 11168H
was transformed with the plasmids. The deletion of 94% of the gene target and
the insertion of the Kanr cassette into Cj1321 were confirmed by PCR using
kanamycin gene-specific primers ak241 and ak240 and primers complementary
to the adjacent genes Cj1320 and Cj1323. The deletion of 93% of the gene target
and the insertion of the Kanr cassette into Cj1323 were confirmed by PCR using
kanamycin gene-specific primers ak241 and ak240 and primers complementary
to the adjacent genes Cj1321 and Cj1324.
Construction of the (Cj1321-Cj1325/6) mutant. PCR was used to amplify a
5-kb region of DNA including 1,049 bp of sequence from the 3 end of Cj1320
and 604 bp of sequence from the 5 end of Cj1327 with primers Cj1321cj1326
locusF1 and Cj1321cj1326locusR1, the 5 ends of which contained a BamHI and
a SphI restriction site, respectively. Details of the primers used are listed in Table
3. The digested PCR product was cloned into BamHI- and SphI-digested pUC19
vector to produce pUC19locus. IPCR was used to generate a product which
included 201 bp of DNA from the 5 end of Cj1321 and 94 bp of DNA from the
3 end of Cj1325/6, with the removal of the remaining sequence between Cj1321
and Cj1325/6 by using BIO-X-ACT long DNA polymerase from Bioline (Lon-
don, United Kingdom) with primers inverse1321 and inverse1326 and
pUC19locus as the template. The 5 ends of primers inverse1321 and inverse1326
contained an HpaI restriction site. An HpaI-digested IPCR product was ligated
with a kanamycin cassette that had been blunt ended with StuI to produce
pUC19invlocus. A clone that contained Kanr in the forward orientation was
selected using primers puc19f and ak241, and this clone was introduced into
11168H by electroporation. A (Cj1321-Cj1325/6) mutant was selected using
CBA and kanamycin, and the mutation was confirmed by PCR and sequencing.
Complementation of Cj1324 and (Cj1321-Cj1325/6). Cj1324 was amplified
from C. jejuni 11168H by using Pwo high-fidelity Taq DNA polymerase (Roche,
United Kingdom) for PCR (94°C for 2 min and 30 cycles of 94°C for 30 s, 45°C
for 30 s, 72°C for 1.5 min, and 72°C for 5 min) with the primers listed in Table
3. SpeI restriction sites were included in the 5 ends of the primers used to
amplify Cj1324. To complement the (Cj1321-Cj1325/6) mutant, the region from
Cj1321 to Cj1325/6 was amplified using Accuprime high-fidelity Taq DNA poly-
merase (Invitrogen, United Kingdom) for PCR (95°C for 15 s and 34 cycles of
95°C for 15 s, 52°C for 15 s, and 68°C for 3 min) with the primers listed in Table
3. SpeI restriction sites were included in the 5 ends of the primers used to
amplify Cj1321 to Cj1325/6. In addition, Shine-Dalgarno (SD) sequences were
incorporated into the forward primer upstream of the start codon for each gene
where possible. For Cj1324, a native SD sequence could not be identified so the
SD sequence corresponding to the gene encoding major outer membrane protein
(PorA) was incorporated instead, as indicated in Table 3. To produce the deliv-
ery vectors, PCR fragments containing each of the genes were digested using
SpeI and cloned into XbaI-digested pRRC in such a way that the genes would be
transcribed in the same orientation as the chloramphenicol resistance gene,
according to the method described in reference 30. Complementation vectors
were sequenced and introduced into the appropriate mutants by electroporation.
Complemented strains were selected using CBA plates containing kanamycin (50
g/ml) and chloramphenicol (30 g/ml). The integration of Cmr-Cj1324 and
Cmr-(Cj1321-Cj1325/6) gene fusions into the rRNA cluster on the 11168H chro-
mosome was verified by PCR as described previously (30).
Autoagglutination assay. Autoagglutination assays were performed as de-
scribed previously by Misawa and Blaser (39), with the modifications detailed
below. Bacterial strains from glycerol stocks were grown on CBA or CBA plates
supplemented with the appropriate antibiotics at 37°C for 48 h and then re-
streaked onto fresh plates and grown overnight. Growth from these plates was
resuspended in phosphate-buffered saline (Sigma-Aldrich, United Kingdom),
and the optical density at 600 nm (OD600) was measured and adjusted to 1.0 	
0.2. Two milliliters of each bacterial suspension was then dispensed into a sterile
glass tube (13 by 100 mm), and the tubes were incubated microaerophilically at
37°C for 24 h in a VAIN. After incubation, 1 ml of the bacterial suspension from
each glass tube was carefully removed and the OD600 was measured. Each strain
was tested in triplicate. To ensure that any observed difference in phenotype was
due to specific mutation, two separate clones for each of the Cj1321, Cj1324,
and Cj1325/6 mutants were tested separately and then the data were combined.
To account for the slight variations between the OD600s of the strains tested, the
data were normalized by subtracting the OD600 measured after 24 h from the
starting OD600, dividing by the starting OD600, and finally multiplying by 100 to
give the percent autoagglutination. Normalized results were plotted using
GraphPad Prism version 4.02. Statistical significance was calculated using the
Student t test, assuming equal variance. Results were considered to be statisti-
cally significant if P was 
0.05.
Hydrophobicity assay. Hydrophobicity was determined by a salting-out
method as described by Misawa and Blaser (39). The minimum concentration of
ammonium sulfate allowing cells to aggregate defines the point of hydrophobic-
ity. Sodium phosphate at 2 mM was used to make serial twofold dilutions of 4 M
ammonium sulfate (25 l each) to a final concentration of 0.00195 M in a
U-bottomed 96-well plate. If a strain had not aggregated at the end point, its
hydrophobicity was assigned as the next twofold dilution, 0.000975 M. Two-day-
old cultures of C. jejuni were resuspended in 2 mM sodium phosphate, and the
TABLE 3. PCR primers used for construction and verification of mutations Cj1321, Cj1323, and Cj1321-26 in 11168H and for
construction of complementation vectors for Cj1324 and Cj1321-26 knockouts
Purpose and target
gene(s) Primer name Sequence
a
Mutagenesis
Cj1321 ak338 GATAAAGATCTCTGCATAGTAAGCAGGTAGTATTATTAGC
ak339 CGCTCAGATCTCTATGATGATGACATTTTTCACGTACTTC
cj1320for GGAAGCACCTATGAAAACAAGG
cj1323rev ATTTGCTAAAGCTCCTCGATTG
Cj1323 ak340 AAATAGATCTCTTTAAAAAGGCCTTATAAAAAGGAATTTTAG
ak341 AAATAGATCTCGCAGTTTAAATCATCCATACTC
cj1321for AAAATGTCATCATCATAGGAGCG
cj1324rev TCTGCACACATTGTTCTATCCC
ak240 GTGGTATGACATTGCCTTCTGCG
ak241 TGGGTTTCAAGCATTAGTCCATGCAAG
Cj1321 to Cj1325/6 Cj1321cj1326locusF1 GCGGATCCGTATCGATAGCGGTTTTGTTT
Cj1321cj1326locusR1 GCGCATGCAACCCACATCAAGCTTAAAAG
inverse1321 GCGTTAACGATTTGTCCTACACCTAAAGC
inverse1326 GCGTTAACCGATAAAGCCGAAGATCTAG
puc19f CTATGCGGCATCAGAGCAGATTG
Complementation
Cj1324 cj1324for GCACTAGTAAGGAGAATTCTCATGATTTATTGTGATCACTGCGTGATGC
cj1324rev GCACTAGTTTATTGTAATTTGTTTTTTAATTTAAATTCTC
Cj1321 to Cj1325/6 iacjlocusF GCACTAGTTAGGAGAAGTACGTCAAAAATGTCATCATCATAGG
iacjlocusR GCACTAGTTTGCCTTTATTTTGCC
a Bases highlighted in bold indicate SpeI restriction sites, and underlined bases correspond to the SD sequence incorporated from the PorA gene.
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OD600 was adjusted to approximately 1.0. Twenty-five microliters of the bacterial
suspension was dispensed into each well, and the plate was incubated at 25°C for
24 h in a Campylobacter GasPak chamber with CampyGen packs (Oxoid, United
Kingdom) to produce microaerophilic conditions. Each strain was tested in
duplicate on at least two separate occasions. Clones 1 and 2 for Cj1321,
Cj1322, Cj1323, Cj1324, and Cj1325/6 were tested separately and then the
data were combined. Statistical significance was calculated using a two-tailed
Mann-Whitney U test. Results were considered to be statistically significant if P
was 
0.05.
Biofilm assay. Biofilm assays were set up using glass tubes (13 by 100 mm) as
described previously (25). Two-day-old bacterial cultures were resuspended in
Brucella broth to an OD600 of 0.04 on average, and 5 ml was dispensed into
each tube. The tubes were incubated microaerophilically at 37°C for 7 days
without shaking. Each strain was tested in triplicate on three separate occasions.
Adhesion and invasion assays. Procedures for the infection of primary chick
kidney cells (CKC) and HD11 avian macrophage-like cells with C. jejuni have
been described previously (55). The adherence of wild-type and mutant strains
was evaluated at 1 h postinoculation of semiconfluent monolayers at a multiplic-
ity of infection of 100:1 by repeated washing of monolayers with prewarmed
phosphate-buffered saline, followed by lysis with 0.5% (vol/vol) Triton X-100 and
the plating of serial 10-fold dilutions of lysates onto sheep blood agar. Intracel-
lular bacteria were enumerated as described above following the incubation of
washed monolayers with gentamicin at a final concentration of 100 g/ml for 1 h
(55). Triplicate determinations within a single assay were performed, and the
data represent the mean 	 standard deviation for three independent biological
replicates of each assay. Similarly, the procedure for quantifying the adhesion of
C. jejuni to human Hep2 cells was performed as described previously (28).
Top-down mass spectrometry (MS) analysis of flagellin. Flagellin was purified
as described previously in reference 13 and was then dialyzed in H2O (with 0.2%
formic acid) by using a Centricon YM-30 membrane filter. The flagellin was
concentrated to 0.2 mg/ml and infused into a Waters quadrupole time-of-flight
mass spectrometer at a flow rate of 0.5 l/min. Multiply protonated flagellin
precursor ions were subjected to top-down analysis according to the method
described in reference 50.
Metabolomic analysis of C. jejuni strains by hydrophilic interaction liquid
chromatography (HILIC)-MS. Cell lysates from overnight 500-ml cultures of C.
jejuni strains and 11168H mutant strains were probed for intracellular sugar
nucleotides as described previously (51). The extraction of sugar nucleotide
sugars was achieved using Envi-Carb solid-phase extraction cartridges as de-
scribed previously (37).
Experimental animals. Animal experiments were performed in accordance
with the Animals (Scientific Procedures) Act of 1986 under PPL 30/2462. Spe-
cific-pathogen-free outbred Light Sussex chickens were produced at the Institute
for Animal Health, Compton, United Kingdom. On the day of hatching, chickens
orally received 0.1 ml of a Campylobacter-free adult gut flora preparation (23).
Inoculated birds were housed in separate rooms in a high-biosecurity facility
until they were 2 weeks old, after which they were used in colonization trials.
Birds were given access to water and a vegetable-based diet (Special Diet Ser-
vices, Manea, Cambridgeshire, United Kingdom) ad libitum.
Colonization trials. Groups of 10 2-week-old birds with developed gut floras
were separately dosed with ca. 107 CFU of the 11168H wild type or a mutant or
complemented strain by oral gavage. Inocula were confirmed to be comparable
by retrospective viable cell count determination. The magnitude and duration of
excretion were monitored at weekly intervals for 6 weeks by a semiquantitative
method reliant on the direct plating of cloacal swabs onto Campylobacter blood-
free selective agar, with incubation in a microaerobic atmosphere at 37°C for 48 h
(56). The swabs were also incubated for 48 h in enrichment broth at 37°C and
then plated onto Campylobacter blood-free selective agar and scored for the
presence of Campylobacter bacteria; the resulting counts were referred to as
enrichment counts. At the end of the trial, postmortem examinations were
performed to enumerate viable bacteria in the intestinal contents at several
points along the intestinal tract. Contents were collected, weighed, and resus-
pended in phosphate-buffered saline to a final concentration of 0.1 g of cecal
contents per ml. Tenfold serial dilutions of each sample were made and plated
onto blood-free medium or medium supplemented with kanamycin (30 g/ml) or
kanamycin (30 g/ml) and chloramphenicol (10 g/ml) to select for mutant or
complemented strains, respectively. The theoretical limit of detection by this
method is 100 CFU/g. Levels of bacteria recovered from different intestinal sites
were analyzed for the effect of the strain by using a two-way analysis with a
general linear model (PROC GLM) after log10 transformation with the Statis-
tical Analysis System, 1995 (SAS Institute, Cary, NC). Pairwise comparisons
were performed using least-squares mean differences at the overall 0.05 level of
significance.
RESULTS
Prevalence of Cj1321, Cj1322, Cj1323, Cj1324, and Cj1325/6
in Campylobacter spp. The strains used in this study are sum-
marized in Table 1. Amino acid sequences predicted from the
Cj1321-Cj1325/6 locus were used to investigate the presence of
similar homologues in other species by BlastX analysis (17).
Degrees of amino acid identity to the Cj1321, Cj1322, Cj1323,
Cj1324, and Cj1325/6 proteins of C. jejuni 11168H were calcu-
lated using EMBOSS with Smith-Waterman local alignment
(46, 57). Orthologues of Cj1321, Cj1322, and Cj1323 were
found in C. jejuni subsp. jejuni 84-25 and C. jejuni subsp. jejuni
CF93-6. Cj1324 and Cj1325/6 were found in larger numbers of
strains. Cj1324 was present in C. jejuni CF93-6, C. jejuni 84-25,
Campylobacter upsaliensis RM3195, and C. coli VC167.
Cj1325/6 was identified in C. coli VC167, C. upsaliensis
RM3195, Campylobacter lari RM2100, C. jejuni 84-25, C. jejuni
CF93-6, and C. jejuni subsp. doylei 269.97.
Mutation of Cj1321, Cj1322, Cj1323, Cj1324, and Cj1325/6
does not affect motility. C. jejuni strain 11168H was chosen for
the investigation of the functions of genes within the locus of
Cj1321 to Cj1325/6. Site-directed mutagenesis was used to
generate knockout mutations of each of the genes individually
by inserting a kanamycin resistance cassette. To ensure that
any differences in phenotypic traits were due to specific muta-
tions in the gene of interest, two independent knockouts
(clones 1 and 2) for each gene were generated. In addition, the
whole locus (Cj1321 to Cj1325/6) was disrupted by allelic re-
placement with a kanamycin resistance cassette. Cj1324 and
(Cj1321-Cj1325/6) were complemented using the method de-
scribed by Karlyshev and Wren (30). Previous studies have
shown that the mutation of a number of genes within the
flagellar glycosylation island can result in the loss of bacterial
motility (19, 21, 62). The swimming motilities of 11168H and
the Cj1321, Cj1322, Cj1323, Cj1324, Cj1325/6, and
(Cj1321-Cj1325/6) mutants were tested using 0.4% Mueller-
Hinton agar plates (11168H flaA was included as a negative
control). All strains displayed swimming motility, as shown in
Fig. 1. In addition, strain 11168H and the Cj1324 and
(Cj1321-Cj1325/6) mutants were examined by electron mi-
croscopy using negative staining and showed no observable
differences in flagella (Fig. 2). Thus, mutations in genes Cj1321
to Cj1325/6 do not affect the assembly of the flagellum or the
motility of the organism.
Cj1324 is involved in autoagglutination and alters hydro-
phobicity in C. jejuni 11168H. The association between auto-
FIG. 1. Swimming motility is not affected by the mutation of
Cj1321, Cj1322, Cj1323, Cj1324, Cj1325/6, or Cj1321 to Cj1325/6. Mo-
tility assays were performed using 0.4% Mueller-Hinton agar inocu-
lated with strains with the indicated genotypes or strain designations
and incubated for 48 h under microaerophillic conditions. The flagel-
lin-negative flaA mutant was also included as a negative control.
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agglutination and virulence for many pathogenic gram-nega-
tive bacteria, including Neisseria gonorrhoeae (58) and
Bordetella pertussis (38), has been described previously. In C.
jejuni, autoagglutination is likely to be controlled by multiple
factors. However, it has been demonstrated that the presence
of FlaA (39) and, more specifically, posttranslational modifi-
cations of flagellin are required for autoagglutination (21, 39).
Given that genes Cj1321 to Cj1325/6 are located within
the flagellin glycosylation locus, 11168H and the Cj1321,
Cj1322, Cj1323, Cj1324, Cj1325/6, and (Cj1321-
Cj1325/6) mutants were tested for their abilities to autoagglu-
tinate. In addition, the flagellin-negative mutant 11168H flaA
was included as a control. The flaA strain exhibited dramat-
ically reduced autoagglutination compared to that of the wild
type, forming a cloudy suspension after 24 h (Fig. 3), as re-
ported previously by Misawa and Blaser (39). The autoagglu-
tination levels of the Cj1321, Cj1322, Cj1323, and
Cj1325/6 strains were comparable to that of the wild-type
strain 11168H, which was approximately 90% after 24 h (data
are shown for the Cj1321, Cj1325/6, and 11168H strains). In
contrast, both the Cj1324 and (Cj1321-Cj1325/6) mutants
had significantly lower levels of autoagglutination, 54 and 60%,
respectively, than the wild-type strain 11168H after 24 h (P 

0.0001). Autoagglutination levels were restored to levels com-
parable to that of 11168H for both the Cj1324 and (Cj1321-
Cj1325/6) strains when the mutations were complemented by
the insertion of the respective wild-type alleles into the chro-
mosome (Fig. 3).
Changes in autoagglutination abilities are strongly associ-
ated with alterations to hydrophobicity (39). Gene-specific
knockouts in the Cj1321, Cj1322, Cj1323, Cj1324,
Cj1325/6, and (Cj1321-Cj1325/6) strains were tested using
the salting-out method to determine the hydrophobicity of
each strain. As shown in Fig. 4, 11168H was strongly hydro-
phobic, aggregating at an average concentration of 0.01 M
ammonium sulfate. Gene knockouts in the Cj1321, Cj1322,
Cj1323, and Cj1325/6 strains did not reduce the hydropho-
bicity of these strains. In contrast, the Cj1324 mutation re-
sulted in a significant reduction in hydrophobicity compared to
that of the wild type, with cells aggregating at an average
concentration of 0.09 M ammonium sulfate (P 
 0.0001). This
reduction in hydrophobicity was eliminated when the mutant
strain was complemented. Further evidence suggesting that
Cj1324 may play a role in altering hydrophobicity was seen in
the (Cj1321-Cj1325/6) mutant, which also showed a signifi-
cant decrease in hydrophobicity, with aggregation at an aver-
age of 0.09 M (P 
 0.0001). Previous research has shown that
the ability of C. jejuni to autoagglutinate can affect both ad-
herence to and invasion of intestinal epithelial cells (18, 21,
39). Given the differences in autoagglutination and hydropho-
bicity observed for the Cj1324 and (Cj1321-Cj1325/6) mu-
tants compared to 11168H, we tested the abilities of these
strains to adhere to and invade primary CKC and an avian
FIG. 2. Transmission electron microscopy analysis of C. jejuni cells. Flagellum production is not affected by the mutation of Cj1324 and Cj1321
to Cj1325/6. The strains examined were as follows: wild-type strain 11168H (A), the Cj1324 mutant (B), and the (Cj1321-Cj1325/6) mutant (C).
Samples were fixed in 2.5% glutaraldehyde–2.5% paraformaldehyde–0.1 M sodium cacodylate buffer, pH 7.4, placed on a grid, and negatively
stained for 1 min with 2% aqueous uranyl acetate before being examined with a Joel 1200EX transmission electron microscope at 80 kV.
FIG. 3. Cj1324, (Cj1321-Cj1325/6), and flaA mutations impair
autoagglutination by C. jejuni 11168H. The bacterial strains specified
by genotype or strain designation along the x axis were resuspended to
an OD600 of approximately 1.0 in phosphate-buffered saline, and the
suspensions were incubated at 37°C under microaerophillic conditions
without shaking. The percent autoagglutination was calculated as de-
scribed in Materials and Methods. comp, complemented strain.
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macrophage-like cell line (HD11) and adhere to human cervix
carcinoma (Hep2) cells. The mean levels of viable bacteria
recovered 	 standard errors (in log10 CFU per milliliter) are
as follows: for bacteria adhering to CKC, 5.02 	 0.71
(11168H), 4.97 	 0.66 (Cj1324 mutant), and 5.00 	 0.47
[(Cj1321-Cj1325/6) mutant]; for bacteria adhering to HD11
cells, 5.93	 0.44 (11168H), 5.43	 0.34 (Cj1324 mutant), and
5.47 	 0.77 [(Cj1321-Cj1325/6) mutant]; for bacteria adher-
ing to Hep2 cells, 4.23 	 0.24 (11168H), 4.43 	 0.24 (Cj1324
mutant), and 4.27 	 0.43 [(Cj1321-Cj1325/6) mutant]; for
bacteria invading CKC, 4.59 	 0.35 (11168H), 4.21 	 0.64
(Cj1324 mutant), and 4.10 	 0.71 [(Cj1321-Cj1325/6) mu-
tant]; and for bacteria invading HD11 cells, 4.89 	 0.74
(11168H), 5.08 	 0.73 (Cj1324 mutant), and 5.15 	 0.83
[(Cj1321-Cj1325/6) mutant]. P values were 0.05 by pairwise
analysis of variance, indicating that differences were not sig-
nificant.
Biofilm formation by the Cj1324 and (Cj1321-Cj1325/6)
mutants is reduced. Several studies have demonstrated that C.
jejuni can form biofilms on abiotic surfaces (25, 26, 44). As
flagella have recently been shown to affect the formation of
biofilms by C. jejuni (44), assays to determine whether Cj1324
and Cj1321 to Cj1325/6 are involved in this trait were per-
formed. Biofilms approximately 2 to 3 mm wide attached to the
walls of glass tubes were clearly visible when 11168H was
tested, as shown in Fig. 5. Previous studies have confirmed that
this observation by electron microscopy is indicative of a ma-
ture biofilm for the wild-type strain 11168H (25). For both the
Cj1324 and (Cj1321-Cj1325/6) mutants, there was a signif-
icant reduction in biofilm formation compared to that by the
wild type after 7 days. When Cj1324 and (Cj1321-Cj1325/6)
were complemented, biofilm formation was restored. There
were no observed differences in biofilm formation between the
Cj1321, Cj1322, Cj1323, or Cj1325/6 mutant and 11168H
(data not shown).
Colonization of chick ceca by Cj1324 and (Cj1321-
Cj1325/6) mutants is reduced. C. jejuni 11168H and the iso-
genic Cj1324 and (Cj1321-Cj1325/6) mutants were sepa-
rately administered to outbred chickens via the oral route, and
the magnitude and duration of excretion were monitored by
semiquantitative direct plating and the enrichment of cloacal
swabs taken at weekly intervals. 11168H colonized 100% of
birds for the first 5 weeks, as determined by the enrichment of
cloacal swabs and in some instances direct plating (Fig. 6A and
FIG. 4. Cj1324 and (Cj1321-Cj1325/6) mutations reduce the
surface hydrophobicity of C. jejuni 11168H. Hydrophobicity was mea-
sured by determining the minimum concentration of ammonium sul-
fate that permitted the aggregation of the bacterial strains specified by
genotype or strain designation along the x axis by using serial twofold
dilutions of a 4 M solution. The end point concentration for this assay
was 0.00195 M ammonium sulfate. comp, complemented strain.
FIG. 5. Cj1324 and (Cj1321-Cj1325/6) mutations impair biofilm
formation. Biofilm assays were performed using 2-day-old cultures
resuspended in 5 ml of Brucella broth to an OD600 of 0.04 and
incubated microaerophilically at 37°C for 7 days without shaking. The
arrow denotes the position of the biofilm on the glass surface above the
meniscus.
FIG. 6. Magnitude and duration of excretion of C. jejuni 11168H
(A), the (Cj1321-Cj1325/6) mutant (B), and the (Cj1321-Cj1325/6)
complemented strain (C) as determined by semiquantitative analyses
of cloacal swabs taken at weekly intervals after the oral inoculation of
outbred chickens. Dark gray bars indicate the percentage of each
group with direct counts of C. jejuni bacteria. White bars indicate the
percentage of each group in which the presence of Campylobacter was
detected only upon enrichment. Birds classified as positive by direct
plating would also be positive by enrichment culture.
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7A), and extensive colonization of distal intestinal sites was
detected by viable cell count determination at postmortem
examination 6 weeks after challenge (Tables 4 and 5). Mean
levels of bacteria recovered from 10 birds per group at post-
mortem examination are presented, and disparity between
these results and the findings from enrichment culture of clo-
acal swabs reflects the relative insensitivity of the latter ap-
proach compared to that of direct plating of intestinal con-
tents. Among (Cj1321-Cj1325/6) mutant-inoculated chickens,
40% of birds were colonized in the first week postinoculation
and 60% of birds (40% detected by direct counting and 20%
detected by enrichment culture) were colonized at 2 weeks
postinoculation (Fig. 6B). The highest level of colonization
detected in birds inoculated with the (Cj1321-Cj1325/6) mu-
tant was 70%, during weeks 3, 4, and 5, after which the mutant
began to be cleared from the birds. The colonization of chick-
ens to levels comparable to those of colonization with 11168H
was observed when (Cj1321-Cj1325/6) was complemented
(Fig. 6C). Similarly, in the case of the Cj1324 mutant, 40% of
chickens were colonized in both the first and second weeks
(Fig. 7B) and levels of colonization reached 70% during weeks
3, 4, and 5, after which the Cj1324 mutant began to be
cleared. The Cj1324 complemented strain also appeared to
be cleared during weeks 3, 4, and 5 but not to the same extent
as the Cj1324 mutant. The numbers of viable bacteria in the
crop, gizzard, jejunum, ileum, and ceca at 6 weeks postinocu-
lation with the (Cj1321-Cj1325/6) and Cj1324 mutants rel-
ative to those at 6 weeks postinoculation with the parent and
complemented strains are recorded in Tables 4 and 5. The
(Cj1321-Cj1325/6) and Cj1324 mutant bacteria were recov-
ered from the cecal contents and cecal tonsils in significantly
lower numbers than bacteria of the parent strain (P
 0.05). In
addition, all sites of the gastrointestinal tract had significantly
lower levels of colonization with the (Cj1321-Cj1325/6) mu-
tant than with 11168H (Table 4) (P 
 0.05). The numbers of
viable bacteria of the (Cj1321-Cj1325/6) complemented and
Cj1324 complemented strains were comparable to those of
the wild type and statistically significantly different from those
of the corresponding mutants at sites where attenuation in
colonization by the mutant strains was detected except the
ileum (Tables 4 and 5), indicating that the attenuation of the
mutant strains is unlikely to be a consequence of secondary
defects. Analysis of the data by a Wilcoxon Mann-Whitney
nonparametric test confirmed the statistically significant atten-
uation of the Cj1324 and (Cj1321-Cj1325/6) strains de-
tected by analysis-of-variance F tests. We also tested the col-
onization of chickens by the Cj1321, Cj1322, Cj1323, and
Cj1325/6 mutants compared to that by 11168H. There were
no observed differences in the colonization of chickens be-
tween the Cj1321, Cj1322, Cj1323, or Cj1325/6 mutant
and 11168H. Also, no significant differences in colonization
FIG. 7. Magnitude and duration of excretion of C. jejuni 11168H (A),
the Cj1324 mutant (B), and Cj1324 complemented strain (C) as de-
termined by semiquantitative analyses of cloacal swabs taken at weekly
intervals after the oral inoculation of outbred chickens. Dark gray bars
indicate the percentage of each group with direct counts of C. jejuni
bacteria. White bars indicate the percentage of each group in which the
presence of C. jejuni was detected only upon enrichment. Birds classified
as positive by direct plating would also be positive by enrichment culture.
TABLE 4. Recovery of viable bacteria of C. jejuni 11168H,
Cj1321-26 mutant, and Cj1321-26 complemented strains
from the gastrointestinal tracts of chickensa
Site in
gastrointestinal
tract
Log no. of CFU of:
11168H Cj1321-26 mutant
Cj1321-26
complemented
strain
Crop 2.9 	 0.14 2.0 	 0.06b 2.9 	 0.17
Gizzard 2.7 	 0.24 2.2 	 0.04b 2.6 	 0.11
Jejunum 2.6 	 0.24 2.0 	 0.07b 3.2 	 0.19
Ileum 4.0 	 0.34 3.3 	 0.04c 3.7 	 0.21
Cecum 7.3 	 0.23 5.7 	 0.47b 8.0 	 0.12
Cecal tonsils 7.1 	 0.13 5.6 	 0.25b 6.8 	 0.19
a Samples were recovered 6 weeks postinoculation (10 birds per strain). Log
values presented are the geometric mean CFU per gram 	 the standard errors
of the means.
b Differences from data for both the parent and the complemented strain are
statistically significant (P 
 0.05).
c The difference from data for the parent is statistically significant (P 
 0.05).
Data for the complemented strain are not statistically significantly different from
those for either the parent or the mutant.
TABLE 5. Recovery of viable bacteria of C. jejuni 11168H,
Cj1324 mutant, and Cj1324 complemented strains
from the gastrointestinal tracts of chickensa
Site in
gastrointestinal
tract
Log no. of CFU of:
11168H Cj1324mutant
Cj1324
complemented strain
Crop 2.7 	 0.2 2.6 	 0.12 2.7 	 0.14
Gizzard 2.5 	 0.06 2.3 	 0.08 2.5 	 0.12
Jejunum 2.4 	 0.1 2.3 	 0.1 2.7 	 0.1
Ileum 3.5 	 0.12 3.3 	 0.17 3.7 	 0.19
Cecum 8.6 	 0.13 7.4 	 0.19b 8.3 	 0.08
Cecal tonsils 6.3 	 0.13 5.5 	 0.25b 6.2 	 0.08
a Samples were recovered 6 weeks postinoculation (10 birds per strain). Log
values presented are the geometric mean CFU per gram 	 the standard errors
of the means.
b Differences from data for both the parent and the complemented strain are
statistically significant (P 
 0.05).
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between these mutants and 11168H at any sites of the gastro-
intestinal tract were found (Table 6).
Metabolomic analysis of 11168H and the Cj1324 mutant.
To investigate the effect of insertional inactivation on the pro-
duction of flagellar glycans, we examined the CMP sugar nu-
cleotide compositions of cell lysates from C. jejuni 11168H and
the corresponding Cj1324 mutant. By using HILIC-MS and
precursor ion scanning for fragment ions characteristic of
CMP, cell lysates from 11168H were found to contain an in-
tracellular pool of CMP-linked sugars (Table 7). CMP-linked
sugars with retention times corresponding to those of the pre-
viously characterized nonulosonate sugars Pse5Ac7Ac (316
Da), Pse5Ac7Am (315 Da), Leg5Ac7Ac (316 Da), Leg5
Am7Ac (315 Da), and Leg5AmNMe7Ac (330 Da) were
present in the metabolome. CMP-N-acetylneuraminic acid
(CMP-Neu5Ac), which correlates with the presence of
Neu5Ac in the lipooligosaccharide (LOS) from this strain, was
also present. In addition, precursor ion scanning experiments
revealed two novel CMP intermediates as negative ions with
m/z values of 711 and 712, with corresponding glycans with
masses of 389 and 390 Da. These glycans were recently shown
to be the novel 2,3-di-O-methylglyceric acid derivatives of
pseudaminic acid and are present on the flagellin of C. jejuni
11168 (33). Metabolomic analysis of the Cj1324 mutant re-
vealed the disappearance of CMP-Leg5Am7Ac and CMP-
Leg5AmNMe7Ac (Table 7), as well as CMP-Pse5Ac7Am.
Complementation of the mutant with the Cj1324 gene restored
both CMP-Leg5Am7Ac and CMP-Leg5AmNMe7Ac but not
CMP-Pse5Ac7Am. This result was consistent for three inde-
pendent clones of the Cj1324 mutant and three correspond-
ing complementation strains. The loss of CMP-Pse5Ac7Am in
the metabolomes of the Cj1324 mutant and the Cj1324
complemented strain may be a consequence of increased in-
corporation of the other Pse derivatives into the flagellin struc-
tural proteins, thus diminishing levels of the nucleotide-acti-
vated precursor in the cytosol. This effect would occur as a
consequence of the inability to synthesize either of the CMP-
legionaminic acid derivatives. The inability to restore a wild-
type profile in complementation experiments may be a reflec-
tion of subtle pathway cross talk/regulatory mechanisms which
we do not yet understand (e.g., pathway intermediate accumu-
TABLE 6. Recovery of viable bacteria of C. jejuni 11168H,
Cj1321 mutant, Cj1322 mutant, Cj1323 mutant, and
Cj1325 mutant strains and corresponding complemented
strains from the gastrointestinal tracts of chickensa
Mutation
Site in
gastrointestinal
tract
Log no. of CFU of:
11168H Deletionmutant
Complemented
strain
Cj1321 Crop 2.39 	 0.75 2.30 	 0.73 2.37 	 0.48
Gizzard 2.35 	 0.40 2.31 	 0.83 2.73 	 0.41
Jejunum 2.46 	 0.63 2.40 	 0.62 2.62 	 0.30
Ileum 3.39 	 0.41 3.35 	 0.18 3.64 	 0.67
Cecum 7.42 	 0.51 7.51 	 0.52 7.70 	 0.91
Cecal tonsils 6.53 	 0.62 6.60 	 0.91 6.47 	 0.84
Cj1322 Crop 2.39 	 0.75 2.28 	 0.88 2.46 	 0.72
Gizzard 2.35 	 0.40 2.33 	 0.13 2.40 	 0.45
Jejunum 2.46 	 0.63 2.32 	 0.85 2.43 	 0.20
Ileum 3.39 	 0.41 3.30 	 0.65 3.50 	 0.97
Cecum 7.42 	 0.51 7.55 	 0.77 7.48 	 0.81
Cecal tonsils 6.53 	 0.62 6.46 	 0.51 6.40 	 0.63
Cj1323 Crop 2.39 	 0.75 2.34 	 0.58 2.29 	 0.13
Gizzard 2.35 	 0.40 2.40 	 0.17 2.30 	 0.74
Jejunum 2.46 	 0.63 2.41 	 0.22 2.44 	 0.24
Ileum 3.39 	 0.41 3.30 	 0.76 3.31 	 0.15
Cecum 7.42 	 0.51 7.37 	 0.59 7.30 	 0.66
Cecal tonsils 6.53 	 0.62 6.49 	 0.88 6.67 	 0.75
Cj1325 Crop 2.39 	 0.75 2.48 	 0.25 2.65 	 0.90
Gizzard 2.35 	 0.40 2.53 	 0.29 2.38 	 0.60
Jejunum 2.46 	 0.63 2.60 	 0.89 2.35 	 0.78
Ileum 3.39 	 0.41 3.58 	 0.80 3.43 	 0.72
Cecum 7.42 	 0.51 7.49 	 0.28 7.56 	 0.92
Cecal tonsils 6.53 	 0.62 6.50 	 0.68 6.61 	 0.36
a Samples were recovered 6 weeks postinoculation (10 birds per strain). Log values
presented are the geometric mean CFU per gram	 the standard errors of the means.
TABLE 7. HILIC-MS analysis of CMP intracellular sugar nucleotidesa
Strain or mutation
Presence of:
CMP
intermediate
(m/z 712;
13.1 min)
CMP-
Leg5Ac7Ac
(m/z 638;
14.1 min)
CMP-
Pse5Ac7Ac
(m/z 638;
14.4 min)
CMP-
Neu5Ac
(m/z 613;
15.7 min)
CMP
intermediate
(m/z 711;
16.9 min)
CMP-
Leg5AmNMe7Ac
(m/z 651;
17.7 min)
CMP-
Leg5Am7Ac
(m/z 637;
18.4 min)
CMP-
Pse5Ac7Am
(m/z 637;
19.2 min)
11168H        
Cj1324        
Cj1324 comp strain        
Cj1321-26        
Cj1321-26 comp strain        
11856b        
12450b        
12567b        
12241c        
15168c        
31467c        
43983c        
80646 (Cj1324)d        
a Values in minutes are retention times. Comp, complemented; , sugar nucleotide not detected; , sugar nucleotide detected.
b Livestock-associated clade.
c Non-livestock-associated clade.
d The Cj1324 gene is present in this non-livestock-associated strain.
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lation and feedback regulation) or may be due to a different
level of gene expression in the complemented strain. For the
whole-locus knockout (Cj1321-Cj1325/6), both CMP-Leg5
Am7Ac and CMP-Leg5AmNMe7Ac disappeared, but these
CMP-linked sugars were restored upon complementation.
Flagellin protein structural analysis. Because the mutation
of the Cj1321-Cj1325/6 locus did not affect flagellin protein
production, we were able to undertake top-down MS analysis
of purified flagellin protein from C. jejuni 11168H and the
corresponding Cj1324 mutant. Analysis of C. jejuni 11168H
flagellin confirmed the presence of monosaccharides corre-
sponding to each of the CMP-linked nucleotide sugars ob-
served in the metabolome. Carbohydrate moieties with masses
of 315, 316, 389, and 390 Da were all present on 11168H
flagellin protein. We were unable to observe the 329-Da mod-
ification on the flagellin protein by top-down analysis, due most
likely to the low abundance of this glycan modification relative
to those of the other flagellar modifications. It should also be
noted that due to identical masses, it is not possible to distin-
guish Pse5Ac7Am from Leg5Am7Ac (315 Da) or Pse5Ac7Ac
from Leg5Ac7Ac (316 Da) by this type of analysis. In contrast,
flagellin from the Cj1324 mutant lacked the 315-Da glycan
yet still contained 389-, 390-, and 317-Da glycans. Complemen-
tation of Cj1324 resulted in flagellin which carried the
315-Da glycan.
Metabolomic analysis of livestock-associated and non-live-
stock-associated clade strains. To determine if the ability to
synthesize the two legionaminic acid derivatives was also
present in other isolates, we next examined the metabolomes
of a number of C. jejuni strains that had been classified previ-
ously by comparative phylogenomic analysis as belonging to
the livestock-associated or non-livestock-associated clade.
Three livestock-associated clade isolates, 11856, 12450, and
12567, which contained the Cj1321-Cj1325/6 locus, all pro-
duced CMP-Leg5Am7Ac and CMP-Leg5AmNMe7Ac, in ad-
dition to all the other CMP-activated sugars found in the
metabolome of 11168H (Table 7). In contrast, the metabo-
lomes of the four tested non-livestock-associated clade strains
(12241, 15168, 31467, and 43983), in which Cj1324 was absent,
all lacked the two novel CMP-Leg derivatives (Table 7). The
metabolomes of two of these strains, 15168 and 31467, were
also lacking CMP-Neu5Ac. Neu5Ac is a component of LOS in
many strains of C. jejuni, and microarray analysis confirmed
that these strains lacked the sialic acid biosynthetic genes to
synthesize the CMP precursor (by microarray analysis, genes
Cj1136 to Cj1145 were found to be absent in strain 15168 and
genes Cj1135 to Cj1145 were found to be absent in strain
31467). A non-livestock-associated clade strain, 80646, which
contained the Cj1324 gene, appeared to still make CMP-Leg5
Am7Ac but not CMP-Leg5AmNMe7Ac (microarray analysis
confirmed that this strain lacks Cj1325/6). In addition, the
metabolome of 80646 appeared to lack the two novel CMP-Pse
2,3-di-O-methylglyceric acid derivatives as negative ions with
m/z values of 711 and 712.
DISCUSSION
In a previous study using whole-genome comparative phy-
logenomic analyses of C. jejuni, we demonstrated that isolates
fall into two distinct groups, a livestock-associated clade, which
contained 31 of 35 livestock strains analyzed, and a non-live-
stock-associated clade (10). The study identified genes associ-
ated with strains of the livestock-associated clade, one of the
most prominent being a cluster of five genes (Cj1321 to
Cj1325/6) adjacent to the structural flagellin genes. Cj1321 to
Cj1325/6 are located within the flagellar glycosylation locus, a
highly variable region of the C. jejuni genome which ranges in
size from 21 to 50 genes. These findings, together with the
location of Cj1321 to Cj1325/6 within strain 11168H, led us to
explore the role these genes may play in flagellum glycosylation
in C. jejuni.
It is becoming increasingly apparent that the glycosylation of
flagella of gram-negative bacteria is important, with glycosyla-
tion modifications increasing the hydrophobicity of flagellin
and often influencing the bacterium’s immunogenicity, inter-
action with eukaryotic cells, and possibly, evasion of natural
predators (9, 51). For Campylobacter, most reports to date
characterizing the O-linked glycosylation of flagellin have fo-
cused on C. coli VC167 and C. jejuni 81-176, which are both
devoid of the Cj1321-Cj1325/6 locus. Furthermore, according
to the results of whole-genome DNA microarray analysis, C.
jejuni 81-176 falls into the non-livestock-associated clade (10).
In C. coli VC167 and C. jejuni 81-176, flagellin glycosylation
has been shown previously to be important in virulence, affect-
ing microcolony formation, autoagglutination, and coloniza-
tion in vivo, by using the ferret diarrheal disease model (21).
Scrutiny of Campylobacter genome sequence data revealed
orthologues of the full locus (Cj1321 to Cj1325/6) in two fur-
ther strains, C. jejuni subsp. jejuni 84-25 and CF93-6. In addi-
tion, orthologues of Cj1324 and Cj1325/6 were found in the
closely related species C. jejuni subsp. doylei 269.27, C. lari
RM2100, C. upsaliensis RM3195, and as previously reported,
C. coli VC167 (36) but were absent in the whole-genome shot-
gun sequence of C. coli RM2228. Why some strains have all of
the genes Cj1321 to Cj1325/6 and others do not is currently
unknown, but this pattern may relate to the host specificities of
different Campylobacter species. C. jejuni is highly recombino-
genic, with multiple mechanisms to vary its glycan content, as
exemplified by both the capsule and LOS loci (16, 27). The
stability of the Cj1321-Cj1325/6 locus during laboratory pas-
sage was monitored, and the locus remained stable, indicating
that it is not easily lost through recombination (S. L. Howard
and B. W. Wren, unpublished data).
Previously, genes within the O-linked flagellum glycosylation
locus have been shown to be essential for flagellation and
motility in C. jejuni and C. coli (19). Mutagenesis in pseB,
involved in the biosynthesis of pseudaminic acid, in strain C.
jejuni 81-176 results in a strain with a nonmotile phenotype
lacking the flagellar filament (19). Motility is essential for the
successful colonization of the intestine in both animals and
humans (23, 40, 41, 60). Gene-specific disruption of Cj1321,
Cj1322, Cj1323, Cj1324, or Cj1325/6 or the removal of the
entire locus (Cj1321 to Cj1325/6) did not affect motility. This
finding supports recently published data from Reid et al., who
reported that the motility of a Cj1324 transposon mutant was
unaffected compared to that of the wild type (45), and data
from previous studies of genes involved in the ptm pathway,
which have shown that mutagenesis in Cj1332 (ptmA) and
Cj1331 (ptmB) does affect motility (20, 62). The presence of
flagella facilitated a top-down MS analysis of selected mutants
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to determine whether genes in the Cj1321-Cj1325/6 locus en-
code novel glycan modifications to flagellin in strain 11168H.
The deletion of Cj1324 and the whole glycosylation locus
(Cj1321 to Cj1325/6) resulted in significant reductions in au-
toagglutination after 24 h (to 54 and 60%, respectively, com-
pared to 90% for 11168H). In addition, the Cj1324 and
(Cj1321-Cj1325/6) mutants showed significant decreases in
hydrophobicity. The results of autoagglutination and hydro-
phobicity assays together with MS data demonstrate that, when
Cj1324 is deleted, Leg5Am7Ac and Leg5AmNMe7Ac glycan
modifications are absent, resulting in a change of the cell
surface charge for the flagellum and the loss of aggregation.
These phenotypic characteristics of the Cj1324 mutant appear
to be due specifically to the alteration of the flagellin-associ-
ated glycan rather than alterations of other C. jejuni glycans
such as LOS and the capsule. The LOS in the mutant appeared
to be identical to that in the wild-type strain upon silver stain-
ing, the capsule appeared to be unaltered upon Alcian blue
staining, and also the Penner serotyping result remained type 2
(unpublished data). The autoagglutination of C. jejuni 81-176
and C. coli VC167 is known to be associated with both the
hydrophobicity of the bacteria and the presence of flagella
(39). The loss of glycosylation with either PseAc or PseAm
results in the failure of the strains to autoagglutinate (21).
Thus, it has been proposed previously that interactions be-
tween these two glycans may both strengthen the flagellum and
aid in autoaggregation through interactions between flagella
(21). Here, we show that in 11168H, glycans Leg5Am7Ac and
Leg5AmNMe7Ac also appear to have a contributory role in
autoagglutination. No significant differences from the wild type
were observed when the Cj1321 and Cj1325/6 mutants were
analyzed in autoagglutination assays or when the Cj1321,
Cj1322, Cj1323, and Cj1325/6 mutants were evaluated in
hydrophobicity assays and chicken colonization studies. The
precise roles of Cj1321, Cj1322, Cj1323, and Cj1325/6 remain
to be determined. Additionally, properties such as autoagglu-
tination and biofilm formation are multifactorial, so the pres-
ence of Cj1324 does not fully explain the mechanisms of these
phenomena. Indeed, several of the non-livestock-associated
strains that lack the Cj1321-Cj1325/6 locus, including strain
81-176, were still able to autoagglutinate and form biofilms
(unpublished data), confirming that numerous factors are in-
volved in these complex physiological processes. Adhesion and
invasion assays using CKC and HEp2 and HD11 cells showed
no significant differences between wild-type and mutant
strains. In a recent study by Guerry et al. in which a pseA
mutant of C. jejuni strain 81-176 (which can no longer synthe-
size the acetamidino form of pseudaminic acid) was tested for
adherence to and invasion of INT407 cells, only minor reduc-
tions compared to those by the wild type were seen (21).
Reeser et al. reported that a flaAB mutation in C. jejuni
M129 results in reduced biofilm formation (this mutant lacks
flagellin and therefore glycan moieties are not present on the
cell surface) (44). In our study, we have shown that the muta-
tion of Cj1324 or the deletion of the whole locus of Cj1321 to
Cj1325/6 in 11168H results in a significant reduction in biofilm
formation after 7 days. Hydrophobic surface components of
bacterial cells, such as flagella, are thought to help overcome
repulsive forces, allowing the bacteria to attach to both hydro-
phobic and hydrophilic surfaces (14, 25). In addition, biofilm
formation has been shown to be important in the colonization
of the urinary tract by uropathogenic strains of E. coli, allowing
the infection to persist through evasion of the host’s defenses
(1). Given that motility was unaffected in all of the mutants in
this study, our results suggest that rather than the presence of
flagella alone, Leg5Am7Ac and Leg5AmNMe7Ac modifica-
tions may contribute to the formation and/or the development
of biofilms.
We investigated the role of O-linked glycosylation in colo-
nization and persistence in the avian intestinal tract. In this
study, (Cj1321-Cj1325/6) and Cj1324 mutants exhibited
prolonged low-level persistence in chickens compared to that
of the parent strain, C. jejuni 11168H. (Cj1321-Cj1325/6)
complementation restored wild-type levels of colonization, and
there was marginal restoration by Cj1324 complementation.
The reasons for the lack of full restoration of persistence of the
Cj1324 complemented strain are unclear. However, the
counts of bacteria of both complemented strains in the avian
intestinal tract were restored to the levels of the parent strain.
These data suggest that the presence of CMP-Leg5Am7Ac and
CMP-Leg5AmNMe7Ac is a contributory factor for the effi-
cient colonization of the cecum. The (Cj1321-Cj1325/6) mu-
tant also exhibited significant defects in the colonization of
various parts of the avian intestinal tract compared to the
parent strain at 6 weeks postinfection, whereas statistically
significant reductions in levels of colonization by the Cj1324
mutant were observed only in the cecal contents and in asso-
ciation with cecal tonsils. The reasons for the different counts
of these mutant bacteria in distinct sites are unknown. The
influences affecting the colonization of avian and human hosts
by enteric bacteria such as C. jejuni are multifactorial and
complex. These factors may involve autoagglutination, micro-
colony formation, surface charge-charge interactions, biofilm
formation, survival under stress (e.g., low-pH stress), the ability
to counteract host immune responses, and direct receptor-
ligand interactions. Campylobacter species have a wide host
range and are found in the gastrointestinal tracts and feces of
many birds and mammals (47, 64). There is overlap in the host
ranges of C. jejuni and C. coli, which both colonize chicken,
pigs, and cattle, and it has been shown previously that genetic
exchange between these two Campylobacter species occurs (12,
53). However, C. jejuni and C. coli also display host specificity,
as they predominate in wild birds and pigs, respectively. We
have shown that glycan modifications to flagellin of C. jejuni
11168H directly affect the colonization of chickens, and we
propose that the modification of flagellin glycosylation may
also play a role in the host specificity of Campylobacter colo-
nization. Interestingly, strain 81-176, a non-livestock-associ-
ated strain originally isolated from milk, colonizes and persists
at a lower level in chickens than 11168H (23).
HILIC-MS and precursor ion scanning were used to selec-
tively analyze the metabolome of C. jejuni 11168H for biosyn-
thetic sugar nucleotides. The metabolome of the Cj1324
mutant revealed the disappearance of CMP-Leg5Am7Ac,
CMP-Leg5AmNMe7Ac, and CMP-Pse5Ac7Am. Both CMP-
Leg5Am7Ac and CMP-Leg5AmNMe7Ac were restored upon
complementation; however, CMP-Pse5Ac7Am was not de-
tected, which may be a consequence of increased utilization of
this nucleotide sugar through incorporation either as a flagellar
glycan or as a substrate in the production of the m/z 711
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CMP-2,3-di-O-methylglyceric acid PseAm derivative. CMP-
Leg5Am7Ac and CMP-Leg5AmNMe7Ac were also detected
in three strains of C. jejuni (11856, 12450, and 12567) which
were classified as livestock associated by comparative phylog-
enomics and possessed Cj1324 (10). Furthermore, confirma-
tion that Cj1324 has a role in the biosynthesis of these novel
legionaminic acid derivatives was demonstrated through the
analysis of four strains from the non-livestock-associated clade.
12241, 15168, 31467, and 43983 lack Cj1324, and HILIC-MS
analysis revealed that CMP-Leg5Am7Ac and CMP-LegAmN
Me7Ac were absent. Thus, we have shown by metabolomic
analyses of additional C. jejuni strains that Cj1324 is involved in
CMP-Leg5Am7Ac and CMP-LegAm7Ac synthesis and that it
is not restricted to the sequenced strain 11168H. The variation
of glycan modifications was exemplified by findings from the
analysis of C. jejuni 80646, which in addition to lacking CMP-
Leg5AmNMe7Ac lacks the two novel CMP-linked sugar inter-
mediates (m/z 711 and 712). CMP-Leg5Am7Ac and CMP-
Leg5AmNMe7Ac have also been found on the flagellin of C.
coli VC167 (36). Although the precise biosynthetic pathway
has yet to be determined, it has been proposed that in C. coli,
ptmG and ptmH encode a CMP-Leg5Am7Ac acetamidino-
synthase and an acetamidino-N-methyltransferase, respectively
(36). We have shown that in C. jejuni 11168H, Cj1324 appears
to have a function similar to that of ptmG, as the loss of Cj1324
results in a loss of metabolites similar to that in the equivalent
mutant of C. coli VC167. The precise function of Cj1324 in the
legionaminic acid biosynthetic pathway is currently being in-
vestigated through enzymatic analysis of recombinant Cj1324
protein.
It is estimated that between 40 and 80% of retail chickens
are contaminated with C. jejuni. C. jejuni can colonize the small
intestines of chickens at levels as high as 109 CFU per g of cecal
contents without the birds’ showing any ill effects (5). Com-
bined with the low infectious dose for humans of500 Campy-
lobacter organisms (6), this situation reinforces the importance
of identifying strategies to reduce levels of colonization in
poultry. This study has, for the first time, provided an expla-
nation (the structural modification of the flagellin glycan) for
why some C. jejuni strains are more likely than others to col-
onize chickens. The discovery of determinants such as Cj1324,
which enhances the ability of C. jejuni to colonize chickens,
should aid rational approaches to reduce the prevalence of this
problematic pathogen in the food chain. This study has vali-
dated the utility of microarray-based methods for whole-ge-
nome comparisons using comparative phylogenomics in iden-
tifying host-specific determinants and confirms the important
and diverse roles that glycosylated flagellins play in bacterial
pathogens, even among members of the same species.
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